市場調査レポート

商品コード

1317682

移植片対宿主病治療市場：疾患タイプ、製品、エンドユーザー別-2023-2030年の世界予測

Graft Versus Host Disease Treatment Market by Disease Type, Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 754,948円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 913,918円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,072,888円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,390,828円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=158.97円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

移植片対宿主病治療の世界市場は、2023年にCAGR 10.38%で18億7,892万米ドルが予測され、2030年には37億6,843万米ドルに達するという驚異的な成長を遂げると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の移植片対宿主病治療市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の発売、未開拓地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.移植片対宿主病治療の世界市場規模および予測は？

2.予測期間中、世界の移植片対宿主病治療市場を形成するCOVID-19の阻害要因と影響は？

3.移植片対宿主病治療の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.移植片対宿主病治療の世界市場における競争戦略は？

5.移植片対宿主病治療の世界市場における技術動向と規制の枠組みは？

6.移植片対宿主病治療の世界市場における主要ベンダーの市場シェアは？

7.移植片対宿主病治療の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 航空貨物の収益とトン数が増加し、大型貨物や重量貨物が増加します
  - 同種移植の数が増加
  - 同種造血幹細胞移植を受ける患者数の増加
- 抑制要因
  - デジタル化による破壊と、世界中の商品の移動を高速化する要求
  - 他の交通手段との競合
  - 治療手順における臨床の進歩
- 機会
  - 新興市場における貨物サービスの成長
  - 新しい航空機技術の技術開発とデジタル化
- 課題
  - 貿易摩擦と業界規制の強化
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章移植片対宿主病治療市場：疾患タイプ別

急性移植片対宿主病
慢性移植片対宿主病

第7章移植片対宿主病治療市場：製品別

コルチコステロイド
モノクローナル抗体
チロシンキナーゼ阻害剤

第8章移植片対宿主病治療市場：エンドユーザー別

病院薬局
オンライン薬局
小売薬局

第9章南北アメリカの移植片対宿主病治療市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第10章アジア太平洋地域の移植片対宿主病治療市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第11章欧州・中東・アフリカの移植片対宿主病治療市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第12章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第13章掲載企業一覧

第14章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. GRAFT VERSUS HOST DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2022 VS 2030 (%)
FIGURE 5. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 6. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 7. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. GRAFT VERSUS HOST DISEASE TREATMENT MARKET DYNAMICS
FIGURE 9. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. GRAFT VERSUS HOST DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 5. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY ACUTE GRAFT VERSUS HOST DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY CHRONIC GRAFT VERSUS HOST DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY TYROSINE KINASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 12. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 26. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 43. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 46. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 80. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 98. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 110. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 113. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. GRAFT VERSUS HOST DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 143. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 144. GRAFT VERSUS HOST DISEASE TREATMENT MARKET LICENSE & PRICING

Product Code: MRR-43676CF4228F

The Global Graft Versus Host Disease Treatment Market is forecasted to grow significantly, with a projected USD 1,878.92 million in 2023 at a CAGR of 10.38% and expected to reach a staggering USD 3,768.43 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Graft Versus Host Disease Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Graft Versus Host Disease Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Disease Type, market is studied across Acute Graft Versus Host Disease and Chronic Graft Versus Host Disease. The Chronic Graft Versus Host Disease is projected to witness significant market share during forecast period.

Based on Product, market is studied across Corticosteroids, Monoclonal Antibodies, and Tyrosine Kinase Inhibitors. The Corticosteroids is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Hospital Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Graft Versus Host Disease Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Graft Versus Host Disease Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Graft Versus Host Disease Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Graft Versus Host Disease Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Graft Versus Host Disease Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Graft Versus Host Disease Treatment Market?

6. What is the market share of the leading vendors in the Global Graft Versus Host Disease Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Graft Versus Host Disease Treatment Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Graft Versus Host Disease Treatment Market, by Disease Type, 2022 vs 2030
4.3. Graft Versus Host Disease Treatment Market, by Product, 2022 vs 2030
4.4. Graft Versus Host Disease Treatment Market, by End-User, 2022 vs 2030
4.5. Graft Versus Host Disease Treatment Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increases in air cargo revenue and tonnage to boost bulky and heavy cargo
  - 5.1.1.2. Growing number of allogeneic transplantations
  - 5.1.1.3. Rising number of patients undergoing allogeneic haematopoietic stem cell transplants
- 5.1.2. Restraints
  - 5.1.2.1. Disruption through digitization and demand to speed-up the movement of goods across the globe
  - 5.1.2.2. Competition from other transport modes
  - 5.1.2.3. Clinical advancements in the treatment procedure
- 5.1.3. Opportunities
  - 5.1.3.1. Growth of cargo services in emerging markets
  - 5.1.3.2. Technological developments in new aircraft technologies and the digitization
- 5.1.4. Challenges
  - 5.1.4.1. Trade tensions and increasing industry regulation
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Graft Versus Host Disease Treatment Market, by Disease Type

6.1. Introduction
6.2. Acute Graft Versus Host Disease
6.3. Chronic Graft Versus Host Disease

7. Graft Versus Host Disease Treatment Market, by Product

7.1. Introduction
7.2. Corticosteroids
7.3. Monoclonal Antibodies
7.4. Tyrosine Kinase Inhibitors

8. Graft Versus Host Disease Treatment Market, by End-User

8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. Americas Graft Versus Host Disease Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Graft Versus Host Disease Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Graft Versus Host Disease Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

移植片対宿主病治療市場：疾患タイプ、製品、エンドユーザー別-2023-2030年の世界予測

Graft Versus Host Disease Treatment Market by Disease Type, Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 移植片対宿主病治療市場：疾患タイプ別

第7章 移植片対宿主病治療市場：製品別

第8章 移植片対宿主病治療市場：エンドユーザー別

第9章 南北アメリカの移植片対宿主病治療市場

第10章 アジア太平洋地域の移植片対宿主病治療市場

第11章 欧州・中東・アフリカの移植片対宿主病治療市場

第12章 競合情勢

第13章 掲載企業一覧

第14章 付録